Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9982060 Bi-specific fusion proteins

Patent 9982060 was granted and assigned to Merrimack Pharmaceuticals on May, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12122819 Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
0
Edits on 30 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Jan, 2024
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+448 characters)
Article

Patent abstract

Bi-specific fusion proteins with therapeutic uses are provided, as well as pharmaceutical compositions comprising such fusion proteins, and methods for using such fusion proteins to repair damaged tissue. The bi-specific fusion proteins generally comprise: (a) a targeting polypeptide domain that binds to an ischemia-associated molecule; and (b) an activator domain that that detectably modulates the activity of a cellular network.

Edits on 1 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 1 Oct, 2023
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Birgit Schoeberl0
Brian Harms0
Bryan Linggi0
Byron DeLaBarre0
Matthew Onsum0
Thomas Wickham0
Ulrik Bjerl Nielsen0
Edits on 14 Jun, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Jun, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11673970 Bi-specific fusion proteins
0
Edits on 22 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 22 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09982060 Bi-specific fusion proteins US Patent 9982060 Bi-specific fusion proteins

Infobox
Patent Number
099820600
Patent Number
99820600
Edits on 23 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
0
Current Assignee
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
099820600
Date of Patent
May 29, 2018
0
Patent Application Number
141877280
Date Filed
February 24, 2014
0
Patent Primary Examiner
‌
Randall L Beane
0
Edits on 20 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 20 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09982060 Bi-specific fusion proteins

Infobox
Is a
Patent
Patent
Patent applicant
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Current assignee
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09982060
Date of patent
May 29, 2018
Patent application number
14187728
Date Filed
February 24, 2014
Patent primary examiner
‌
Randall L Beane

Find more entities like US Patent 9982060 Bi-specific fusion proteins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo